| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 4.481 | 39.810 | 60.475 | 63.203 | 92.028 | 71.381 | 138.860 | 177.589 |
| Total Income - EUR | - | - | 4.481 | 40.325 | 65.775 | 74.925 | 97.419 | 77.011 | 143.590 | 179.546 |
| Total Expenses - EUR | - | - | 5.572 | 39.978 | 71.505 | 74.462 | 95.082 | 82.897 | 143.953 | 229.454 |
| Gross Profit/Loss - EUR | - | - | -1.091 | 347 | -5.730 | 463 | 2.336 | -5.885 | -363 | -49.908 |
| Net Profit/Loss - EUR | - | - | -1.226 | -862 | -6.335 | -179 | 1.415 | -6.579 | -1.753 | -50.577 |
| Employees | - | - | 0 | 0 | 3 | 2 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Maromibamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 823 | 4.905 | 2.923 | 1.632 | 301 | 1.089 | 38.435 | 68.541 |
| Current Assets | - | - | 770 | 2.968 | 777 | 7.432 | 8.235 | 28.060 | 39.488 | 53.861 |
| Inventories | - | - | 0 | 318 | 0 | 1.613 | 2.171 | 9.315 | 24.765 | 12.644 |
| Receivables | - | - | 519 | 0 | 316 | 0 | 2.969 | 8.851 | 11.382 | 34.569 |
| Cash | - | - | 251 | 2.650 | 461 | 5.819 | 3.095 | 9.894 | 3.342 | 6.647 |
| Shareholders Funds | - | - | -1.182 | -2.022 | -8.318 | -8.340 | -7.226 | -13.827 | -15.538 | -66.028 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 2.775 | 9.895 | 12.018 | 17.403 | 15.763 | 42.975 | 93.461 | 188.430 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Maromibamed Srl